Symptom-specific effects of counselling for depression compared to cognitive-behavioural therapy.
Adult psychiatry
Depression & mood disorders
Journal
BMJ mental health
ISSN: 2755-9734
Titre abrégé: BMJ Ment Health
Pays: England
ID NLM: 9918521385306676
Informations de publication
Date de publication:
02 2023
02 2023
Historique:
received:
28
10
2022
accepted:
08
02
2023
entrez:
15
2
2023
pubmed:
16
2
2023
medline:
18
2
2023
Statut:
ppublish
Résumé
Cognitive-behavioural therapy (CBT) and counselling for depression (CfD) are recommended first-line treatments for depression. While they approach change differently, there is little understanding of the impact those approaches have on change during treatment. This study aimed to identify whether CBT and CfD target different symptoms and explore the implications of modelling choices when quantifying change during treatment. Symptom-specific effects of treatment were identified using moderated network modelling. This was a retrospective cohort study of 12 756 individuals who received CBT or CfD for depression in primary/community care psychological therapy services in England. Change was modelled several ways within the whole sample and a propensity score matched sample (n=3446). CBT for depression directly affected excessive worry, trouble relaxing and apprehensive expectation and had a stronger influence on changes between suicidal ideation and concentration. CfD had a stronger direct influence on thoughts of being a failure and on the associated change between being an easily annoyed and apprehensive of expectation. There were inconsistencies when modelling change using the first and second appointments as the baseline. Residual score models produced more conservative findings than models using difference scores. CfD and CBT for depression have differential effects on symptoms demonstrating specific mechanisms of change. CBT was uniquely associated with changes in symptoms associated with anxiety and may be better suited to those with anxiety symptoms comorbid to their depression. When assessing change, the baseline should be the first therapy session, not the pretreatment assessment. Residual change scores should be preferred over difference score methods.
Sections du résumé
BACKGROUND
Cognitive-behavioural therapy (CBT) and counselling for depression (CfD) are recommended first-line treatments for depression. While they approach change differently, there is little understanding of the impact those approaches have on change during treatment.
OBJECTIVES
This study aimed to identify whether CBT and CfD target different symptoms and explore the implications of modelling choices when quantifying change during treatment.
METHODS
Symptom-specific effects of treatment were identified using moderated network modelling. This was a retrospective cohort study of 12 756 individuals who received CBT or CfD for depression in primary/community care psychological therapy services in England. Change was modelled several ways within the whole sample and a propensity score matched sample (n=3446).
FINDINGS
CBT for depression directly affected excessive worry, trouble relaxing and apprehensive expectation and had a stronger influence on changes between suicidal ideation and concentration. CfD had a stronger direct influence on thoughts of being a failure and on the associated change between being an easily annoyed and apprehensive of expectation. There were inconsistencies when modelling change using the first and second appointments as the baseline. Residual score models produced more conservative findings than models using difference scores.
CONCLUSIONS
CfD and CBT for depression have differential effects on symptoms demonstrating specific mechanisms of change.
CLINICAL IMPLICATIONS
CBT was uniquely associated with changes in symptoms associated with anxiety and may be better suited to those with anxiety symptoms comorbid to their depression. When assessing change, the baseline should be the first therapy session, not the pretreatment assessment. Residual change scores should be preferred over difference score methods.
Identifiants
pubmed: 36792174
pii: bmjment-2022-300621
doi: 10.1136/bmjment-2022-300621
pmc: PMC10035778
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Wellcome Trust
ID : 201292/Z/16/Z
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: JEJB has received grants from the Wellcome Trust and University College London. SP has received grants from the National Institute of Health Research and the National Institute of Health Research University College London Hospitals Biomedical Research Centre. RS receives support from NHS England. JEJB, RS and SP have received a grant from the Royal College of Psychiatrists.
Références
J Behav Ther Exp Psychiatry. 2019 Jun;63:6-11
pubmed: 30551055
Perspect Psychol Sci. 2017 Nov;12(6):999-1020
pubmed: 28873325
Behav Res Ther. 2018 Jul;106:71-85
pubmed: 29699700
World Psychiatry. 2021 Oct;20(3):363-375
pubmed: 34505370
J Clin Psychiatry. 2013 Jun;74(6):595-602
pubmed: 23842011
BMJ. 2001 Nov 10;323(7321):1123-4
pubmed: 11701584
Psychother Psychosom. 2019;88(1):52-54
pubmed: 30625483
Cogn Behav Therap. 2020 Jun 09;13:e16
pubmed: 33613689
Psychol Med. 2023 Jan;53(2):408-418
pubmed: 33952358
J Biom Biostat. 2017 Feb 24;8(1):1-8
pubmed: 30555734
Behav Res Ther. 2020 Aug;131:103637
pubmed: 32413595
Behav Res Ther. 2019 Nov;122:103440
pubmed: 31542565
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Annu Rev Clin Psychol. 2018 May 7;14:209-236
pubmed: 29494258
Behav Res Ther. 2020 Jan;124:103505
pubmed: 31841709
J Consult Clin Psychol. 2008 Dec;76(6):909-22
pubmed: 19045960
J Consult Clin Psychol. 2020 Jan;88(1):14-24
pubmed: 31841021
Psychol Methods. 2010 Sep;15(3):250-67
pubmed: 20822251
Psychol Med. 2021 May;51(7):1068-1081
pubmed: 33849685
Annu Rev Clin Psychol. 2018 May 7;14:159-183
pubmed: 29350997
Multivariate Behav Res. 2021 Mar-Apr;56(2):256-287
pubmed: 31782672
Sleep Med. 2023 Jan;101:505-514
pubmed: 36527942
BMC Psychiatry. 2017 Jun 9;17(1):215
pubmed: 28599621
J Consult Clin Psychol. 2016 Aug;84(8):738-51
pubmed: 27213493
Psychother Res. 2020 Jun;30(5):650-661
pubmed: 31382844
JAMA Psychiatry. 2022 May 1;79(5):406-416
pubmed: 35262620
Lancet Psychiatry. 2021 Jun;8(6):487-499
pubmed: 34000240
Psychother Psychosom. 2018;87(2):121-123
pubmed: 29495015
Sci Rep. 2022 Jun 27;12(1):10881
pubmed: 35760940
J Gen Intern Med. 2001 Sep;16(9):606-13
pubmed: 11556941